CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to AZN

BGF MDI HFO 320/14.4/9.6μg

Phase 3
AstraZeneca PLC (AZN)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in COPD (Chronic Obstructive Pulmonary Disease)

View Full Landscape
Drug Information

Target Indication

COPD (Chronic Obstructive Pulmonary Disease)

Clinical Trial

NCT06075095

Last updated: 2/9/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.